A majority of healthcare leaders cite high drug costs as a major challenge for their organization, according to a new Premier survey.
Premier polled 91 leaders — including C-suite members, supply chain leaders, financial executives and physicians — from health systems across the country. The online survey, part of Premier's biannual Economic Outlook report, was conducted in winter 2017.
Here are four survey findings.
1. Ninety-nine percent of respondents said price hikes pose a challenge to their organization.
2. More than 90 percent of respondents said drug shortages will continue to be an issue at the organization over the next three years.
3. More than 90 percent of leaders expect the expansion of personalized or precision medicine to increase their supply chain spend.
4. Nearly 70 percent of respondents believe their hospital or health system will need to operate its own specialty pharmacy.
More articles on supply chain:
Drug companies unite around March for Science: 4 things to know
4 latest FDA approvals
Valeant's new plaque psoriasis drug to cost $3.5k per month